Filing Flows › Fresenius Medical Care AG (FMS) › Q3 2026 › vs Q3 2025
Fresenius Medical Care AG (FMS) Q3 2026 vs Q3 2025 (year over year)
Fresenius Medical Care AG's revenue rose $104M (+1%) from $9.8B in Q3 2025 to $9.9B in Q3 2026. The biggest changes: Healthcare services +$93.0M (+3%); Insurance contracts −$63.8M (-11%); 2 a), 14 +$51.9M (+1%). Operating margin 3.9% against 4.9% (-1.0 pts).
Fresenius Medical Care AG, Q3 2026: revenue $9.9B (+1% year over year), operating margin 3.9%, net earnings $160M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 3.9% | 4.9% | -1.0 pts |
| Net margin | 1.6% | 2.8% | -1.2 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| 2 a), 14 | $4.9B | $4.9B | $51.9M | +1% |
| Healthcare services | $3.3B | $3.2B | $93.0M | +3% |
| Healthcare products | $1.1B | $1.1B | $22.7M | +2% |
| Insurance contracts | $504M | $568M | −$63.8M | -11% |
| Revenue | $9.9B | $9.8B | $104M | +1% |
| Operating profit | $384M | $477M | −$92.4M | -19% |
| Costs & expenses | $9.5B | $9.3B | $196M | +2% |
| Pre-tax earnings | $303M | $403M | −$99.9M | -25% |
| Other expense, net | $81.5M | $73.9M | $7.5M | +10% |
| Research & development | $41.4M | $37.7M | $3.6M | +10% |
| SG&A | $744M | $705M | $38.2M | +5% |
| Other operating costs | $8.7B | $8.6B | $154M | +2% |
| Net earnings | $160M | $275M | −$115M | -42% |
| Minority interests | $65.0M | $52.5M | $12.5M | +24% |
| Income tax | $77.8M | $75.2M | $2.6M | +3% |
Questions
How much did Fresenius Medical Care AG's revenue grow year over year in Q3 2026?
Fresenius Medical Care AG's revenue rose $104M (+1%) from $9.8B in Q3 2025 to $9.9B in Q3 2026.
What drove Fresenius Medical Care AG's revenue change in Q3 2026?
Healthcare services +$93.0M (+3%); Insurance contracts −$63.8M (-11%); 2 a), 14 +$51.9M (+1%).